Biotechnology University of Manitoba
Biotechnology is the application of the principles of chemistry, biochemistry and microbiology to the development of new technologies. Both Microbiology and Chemistry share in the teaching and administration of the program, The Honours and cooperative work-study (co-op) programs provide experience in government, private sector and research laboratories.
B.Sc. Bachelor of Science, Honours in Biotechnology – 4 years
B.Sc. Bachelor of Science, Honours in Biotechnology (Co-op) – 5 years
B.Sc. Bachelor of Science, Major in Biotechnology – 4 years
B.Sc. Bachelor of Science, Major in Biotechnology (Co-op) – 5 years
Interesting courses and unique opportunities
- Industrial Bioprocesses
- Biological Energy Transduction
- Drug Design and Drug Discovery
Research opportunities are available in the department during the summer or as part of an Honours program.
Cooperative-work study options for Major and Honours Programs
- Public health
- Industrial microbiology or chemistry: producing antibiotics, vaccines, bioethanol, enzymes and antibodies
- Basic research
- Graduate studies
Visit the Science Direct Entry (high school applicants) or Advanced Entry (post-secondary applicants) application for admission page to learn more about admission requirements, application dates and how to apply.
What is unique about this program at the U of M?
Students have the opportunity to combine two fascinating areas of life sciences with a real world application and impact. They also have an opportunity to work with excellent faculty members from two departments, all who have externally-funded research programs, including three with national research chairs. Students will experience hands-on research opportunities, strong links to other programs in Science and other faculties, preparation for graduate programs and excellent undergraduate laboratories.
A growing area of treatment for cancer and other potentially deadly disorders is biopharmaceuticals, which provide patients with the disease-killing antibodies they aren't producing but which they require to fight disease. These drugs, made of therapeutic human monoclonal antibodies (known as Mabs), are so in demand that their global sales jumped from $300 million in 1997 to $25 billion in 2007.
Algal biotechnology in the Asia-Pacific region: Proceedings of the First Asia-Pacific Conference on Algal Biotechnology held on 29-31 January 1992 at the University of Malaya
Book (Institute of Advanced Studies, University of Malaya)